Evoke Pharma (EVOK) Tops Q2 EPS by 4c

Evoke Pharma (NASDAQ: EVOK) reported Q2 EPS of ($0.11), $0.04 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity